Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 7.15 INR
Change Today 0.00 / 0.00%
Volume 0.0
CLZ On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

colinz laboratories ltd (CLZ) Snapshot

Open
7.15
Previous Close
7.15
Day High
7.15
Day Low
7.15
52 Week High
04/23/15 - 19.45
52 Week Low
10/29/14 - 3.56
Market Cap
32.7M
Average Volume 10 Days
97.8
EPS TTM
0.21
Shares Outstanding
4.6M
EX-Date
--
P/E TM
34.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for COLINZ LABORATORIES LTD (CLZ)

Related News

No related news articles were found.

colinz laboratories ltd (CLZ) Related Businessweek News

No Related Businessweek News Found

colinz laboratories ltd (CLZ) Details

Colinz Laboratories Limited manufactures and markets pharmaceutical formulations primarily for the gynaecological sector in India. The company provides specialty products in the dosage form of tablets, capsules, parenterals, creams/ointments/lotions, dry powders, liquid orals, and soft gelatine capsules. It offers its products in various therapeutic areas, including anti biotics and anti bacterials, anti hypertensives, diuretics, lipid lowering agents, anti emetics, anti fungals, pain killers and musculo skeletals, anxiolytics, anti allergics, anti cold and anti cough, nasal decongestants, anti diarrhoeals, gastro intestinals/antacids, anti helmintics, laxatives and purgatives, enzymes, vitamins and tonics, iron, calcium, amino acids, anti piles, anti malarials, skin creams, eye drops, and ear drops, as well as drugs used in protozoal infections. In addition, the company provides veterinary formulations, such as feed mixes, bolus, vitamins, and other products; nutraceuticals; pain balms and anti cold rubs; ayurvedic skin care creams for the treatment of pimples, fairness, stretch marks, and cracks; and capsules/tablets/ creams/ powders for anti piles, laxatives, anti diabetic, anti hypertensive, antacid, vigour and vitality, and general debility. Further, it sources APIs/intermediates; and provides product development and clinical research services, technical know how for formulations, and contract manufacturing services. Colinz Laboratories Limited was incorporated in 1986 and is based in Mumbai, India.

Founded in 1986

colinz laboratories ltd (CLZ) Top Compensated Officers

Chairman, Managing Director, Member of Audit ...
Total Annual Compensation: 885.5K
Whole-Time Director
Total Annual Compensation: 795.5K
Compensation as of Fiscal Year 2014.

colinz laboratories ltd (CLZ) Key Developments

Colinz Laboratories Ltd. Reports Audited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2015

Colinz Laboratories Ltd. reported audited standalone earnings results for the fourth quarter and year ended March 31, 2015. For the quarter, the company reported net sales of INR 17,060,000 compared to INR 17,976,000 a year ago. Profit from operations before other income was INR 189,000 compared to INR 130,000 a year ago. Profit before tax was INR 181,000 compared to INR 542,000 a year ago. Net profit after tax was INR 181,000 compared to INR 542,000 a year ago. For the full year, the company reported net sales of INR 78,857,000 compared to INR 74,028,000 a year ago. Profit from operations before other income was INR 1,503,000 compared to INR 833,000 a year ago. Profit before tax was INR 1,455,000 compared to INR 1,265,000 a year ago. Net profit after tax was INR 965,000 compared to INR 665,000 a year ago. Basic and diluted earnings per share before after extraordinary items were INR 0.21 compared to INR 0.15 a year ago.

Colinz Laboratories Ltd., Board Meeting, May 30, 2015

Colinz Laboratories Ltd., Board Meeting, May 30, 2015. Agenda: To consider the audited standalone earnings results for the fourth quarter and year ended March 31, 2015.

Colinz Laboratories Ltd. Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Colinz Laboratories Ltd. announced unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported net sales/income from operations of INR 18,531,000 compared to INR 18,287,000 for the same period a year ago. Profit from operations before other income was INR 474,000 compared to loss from operations before other income of INR 66,000 for the same period a year ago. Profit before tax was INR 357,000 compared to INR 300,000 for the same period a year ago. Net profit after tax was INR 232,000 compared to INR 300,000 for the same period a year ago. For the nine months, the company reported net sales/income from operations of INR 61,797,000 compared to INR 56,052,000 for the same period a year ago. Profit from operations before other income was INR 1,313,000 compared to INR 703,000 for the same period a year ago. Profit before tax was INR 1,275,000 compared to INR 723,000 for the same period a year ago. Net profit after tax was INR 885,000 compared to INR 723,000 for the same period a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLZ:IN 7.15 INR 0.00

CLZ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CLZ.
View Industry Companies
 

Industry Analysis

CLZ

Industry Average

Valuation CLZ Industry Range
Price/Earnings 33.4x
Price/Sales 0.4x
Price/Book 0.5x
Price/Cash Flow 8.1x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COLINZ LABORATORIES LTD, please visit www.colinz.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.